Studies have shown that lower expression levels of HLA-DQB1 in lung adenocarcinoma tissue correlate with a reduced recurrence rate in patients, indicating its significant role in the immune response and prognosis of lung adenocarcinoma [30]. This evidence concerns the gene HLA-DQB1 and lung adenocarcinoma.